Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19173048 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL29125008 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL30954764 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL203262 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL19172281 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL23015072 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL1069647 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL2786532 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL1008189 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 | |
| SCHEMBL1009635 | 1.00 | MEN1 (0.54) | MEN1KMT2AKDM4CL3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100551887-C | A kind of preparation method of policosanol | UNIV XIAMEN (CN) | 2009-10-21 | — | — | CN | claimed |
| CN-101121636-A | Preparation method for octacosanol | UNIV XIAMEN (CN) | 2008-02-13 | — | — | CN | claimed |
| EP-4549426-A1 | METHOD FOR PRODUCING VERY-LONG-CHAIN POLYUNSATURATED FATTY ACID | Nissui Corporation (JP) | 2025-05-07 | — | — | EP | disclosed |
| CN-119173496-A | Method for producing ultra-long-chain polyunsaturated fatty acid | 株式会社日水 | 2024-12-20 | — | — | CN | disclosed |
| US-20240360163-A1 | Nucleoside Prodrugs and Uses Related Thereto | UNIV EMORY (US) | 2024-10-31 | — | — | US | disclosed |
| US-12049474-B2 | Nucleoside prodrugs and uses related thereto | EMORY UNIVERSITY (US) | 2024-07-30 | — | — | US | disclosed |
| CN-115991664-B | Naphthoquinone oxime derivative with antibacterial activity and medical application thereof | 上海交通大学 | 2024-07-26 | — | — | CN | disclosed |
| WO-2024005039-A1 | METHOD FOR PRODUCING VERY-LONG-CHAIN POLYUNSATURATED FATTY ACID | 株式会社ニッスイ | 2024-01-04 | — | — | WO | disclosed |
| US-20230242944-A1 | METHODS FOR PRODUCTION OF DIATRAEA SACCHARALIS PHEROMONE PRECURSORS | SEMIOPLANT AB (SE) | 2023-08-03 | — | — | US | disclosed |
| US-20230226002-A1 | RETINAL BIOAVAILBILITY OF SYNTHETIC VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2023-07-20 | — | — | US | disclosed |
| US-20230226002-A1 | RETINAL BIOAVAILBILITY OF SYNTHETIC VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2023-07-20 | — | — | US | disclosed |
| EP-0719258-B1 | CYCLIC AMIDE DERIVATIVES FOR PROTECTING AGAINST ULTRAVIOLET RAYS | OTSUKA PHARMA CO LTD (JP) | 2001-10-31 | — | — | EP | disclosed |
| WO-2000037453-A1 | PHOTOACTIVE PROPANE DERIVATIVES AND ORIENTATION LAYERS | QINETIQ LIMITED (GB) | 2000-06-29 | — | — | WO | disclosed |
| US-5786367-A | OXYGEN SCAVENGERS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-07-28 | — | — | US | disclosed |
| EP-0251786-B1 | Alkynylamino-nucleotides | DU PONT (US) | 1994-11-30 | — | — | EP | disclosed |
| WO-1994011343-A1 | LONG CHAIN FATTY ALCOHOLS WITH NEUROTROPHIC AND PARAMNESIC ACTIVITY, AND METHOD OF PREPARATION | MEDAFOR (FR) | 1994-05-26 | — | — | WO | disclosed |
| EP-0593831-A1 | Long-chain fatty alcohols as neurotrophic and memory improving agents | MEDAFOR (FR) | 1994-04-27 | — | — | EP | disclosed |
| US-5151507-A | Alkynylamino-nucleotides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-09-29 | — | — | US | disclosed |
| US-5047519-A | Alkynylamino-nucleotides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-09-10 | — | — | US | disclosed |
| EP-0251786-A2 | Alkynylamino-nucleotides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240360163-A1 | Nucleoside Prodrugs and Uses Related Thereto | PNPO, GSTO1, CYP2C18 | MEN1 4325/4885KMT2A 3065/4885KDM4C 3438/4885 |
| US-12049474-B2 | Nucleoside prodrugs and uses related thereto | PNPO, GSTO1, CYP2C18 | MEN1 4325/4885KMT2A 3065/4885KDM4C 3438/4885 |
| US-20230226002-A1 | RETINAL BIOAVAILBILITY OF SYNTHETIC VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS | ELOVL1, ELOVL3, FFAR2 | MEN1 3848/4885KMT2A 3613/4885KDM4C 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.